Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis
Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to t...
Saved in:
Published in | American journal of respiratory and critical care medicine Vol. 200; no. 2; pp. 199 - 208 |
---|---|
Main Authors | , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
American Thoracic Society
15.07.2019
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung.
To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease.
We performed deep targeted resequencing (3.69 Mb of DNA) in cases (
= 3,624) and control subjects (
= 4,442) across genes and regions previously associated with disease. We tested for associations between disease and
) individual common variants via logistic regression and
) groups of rare variants via sequence kernel association tests.
Statistically significant common variant association signals occurred in all 10 of the regions chosen based on genome-wide association studies. The strongest risk variant is the
promoter variant rs35705950, with an odds ratio of 5.45 (95% confidence interval, 4.91-6.06) for one copy of the risk allele and 18.68 (95% confidence interval, 13.34-26.17) for two copies of the risk allele (
= 9.60 × 10
). In addition to identifying for the first time that rare variation in
is associated with disease, we confirmed the role of rare variation in the
and
gene regions in the risk of IPF, and found that the
and
regions have independent common and rare variant signals.
A limited number of common and rare variants contribute to the risk of idiopathic pulmonary fibrosis in each of the resequencing regions, and these genetic variants focus on biological mechanisms of host defense and cell senescence. |
---|---|
AbstractList | Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung.
To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease.
We performed deep targeted resequencing (3.69 Mb of DNA) in cases (
= 3,624) and control subjects (
= 4,442) across genes and regions previously associated with disease. We tested for associations between disease and
) individual common variants via logistic regression and
) groups of rare variants via sequence kernel association tests.
Statistically significant common variant association signals occurred in all 10 of the regions chosen based on genome-wide association studies. The strongest risk variant is the
promoter variant rs35705950, with an odds ratio of 5.45 (95% confidence interval, 4.91-6.06) for one copy of the risk allele and 18.68 (95% confidence interval, 13.34-26.17) for two copies of the risk allele (
= 9.60 × 10
). In addition to identifying for the first time that rare variation in
is associated with disease, we confirmed the role of rare variation in the
and
gene regions in the risk of IPF, and found that the
and
regions have independent common and rare variant signals.
A limited number of common and rare variants contribute to the risk of idiopathic pulmonary fibrosis in each of the resequencing regions, and these genetic variants focus on biological mechanisms of host defense and cell senescence. Rationale: Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease. Methods: We performed deep targeted resequencing (3.69 Mb of DNA) in cases (n = 3,624) and control subjects (n = 4,442) across genes and regions previously associated with disease. We tested for associations between disease and 1) individual common variants via logistic regression and 2) groups of rare variants via sequence kernel association tests. Measurements and Main Results: Statistically significant common variant association signals occurred in all 10 of the regions chosen based on genome-wide association studies. The strongest risk variant is the MUC5B promoter variant rs35705950, with an odds ratio of 5.45 (95% confidence interval, 4.91–6.06) for one copy of the risk allele and 18.68 (95% confidence interval, 13.34–26.17) for two copies of the risk allele (P = 9.60 × 10−295). In addition to identifying for the first time that rare variation in FAM13A is associated with disease, we confirmed the role of rare variation in the TERT and RTEL1 gene regions in the risk of IPF, and found that the FAM13A and TERT regions have independent common and rare variant signals. Conclusions: A limited number of common and rare variants contribute to the risk of idiopathic pulmonary fibrosis in each of the resequencing regions, and these genetic variants focus on biological mechanisms of host defense and cell senescence. Rationale: Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease. Methods: We performed deep targeted resequencing (3.69 Mb of DNA) in cases (n = 3,624) and control subjects (n = 4,442) across genes and regions previously associated with disease. We tested for associations between disease and 1) individual common variants via logistic regression and 2) groups of rare variants via sequence kernel association tests. Measurements and Main Results: Statistically significant common variant association signals occurred in all 10 of the regions chosen based on genome-wide association studies. The strongest risk variant is the MUC5B promoter variant rs35705950, with an odds ratio of 5.45 (95% confidence interval, 4.91-6.06) for one copy of the risk allele and 18.68 (95% confidence interval, 13.34-26.17) for two copies of the risk allele (P = 9.60 × 10-295). In addition to identifying for the first time that rare variation in FAM13A is associated with disease, we confirmed the role of rare variation in the TERT and RTEL1 gene regions in the risk of IPF, and found that the FAM13A and TERT regions have independent common and rare variant signals. Conclusions: A limited number of common and rare variants contribute to the risk of idiopathic pulmonary fibrosis in each of the resequencing regions, and these genetic variants focus on biological mechanisms of host defense and cell senescence.Rationale: Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease. Methods: We performed deep targeted resequencing (3.69 Mb of DNA) in cases (n = 3,624) and control subjects (n = 4,442) across genes and regions previously associated with disease. We tested for associations between disease and 1) individual common variants via logistic regression and 2) groups of rare variants via sequence kernel association tests. Measurements and Main Results: Statistically significant common variant association signals occurred in all 10 of the regions chosen based on genome-wide association studies. The strongest risk variant is the MUC5B promoter variant rs35705950, with an odds ratio of 5.45 (95% confidence interval, 4.91-6.06) for one copy of the risk allele and 18.68 (95% confidence interval, 13.34-26.17) for two copies of the risk allele (P = 9.60 × 10-295). In addition to identifying for the first time that rare variation in FAM13A is associated with disease, we confirmed the role of rare variation in the TERT and RTEL1 gene regions in the risk of IPF, and found that the FAM13A and TERT regions have independent common and rare variant signals. Conclusions: A limited number of common and rare variants contribute to the risk of idiopathic pulmonary fibrosis in each of the resequencing regions, and these genetic variants focus on biological mechanisms of host defense and cell senescence. Rationale: Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the lung. Objectives: To develop an integrated understanding of the rare and common variants located in multiple loci that have been reported to contribute to the risk of disease. Methods: We performed deep targeted resequencing (3.69 Mb of DNA) in cases ( n = 3,624) and control subjects ( n = 4,442) across genes and regions previously associated with disease. We tested for associations between disease and 1 ) individual common variants via logistic regression and 2 ) groups of rare variants via sequence kernel association tests. Measurements and Main Results: Statistically significant common variant association signals occurred in all 10 of the regions chosen based on genome-wide association studies. The strongest risk variant is the MUC5B promoter variant rs35705950, with an odds ratio of 5.45 (95% confidence interval, 4.91–6.06) for one copy of the risk allele and 18.68 (95% confidence interval, 13.34–26.17) for two copies of the risk allele ( P = 9.60 × 10 −295 ). In addition to identifying for the first time that rare variation in FAM13A is associated with disease, we confirmed the role of rare variation in the TERT and RTEL1 gene regions in the risk of IPF, and found that the FAM13A and TERT regions have independent common and rare variant signals. Conclusions: A limited number of common and rare variants contribute to the risk of idiopathic pulmonary fibrosis in each of the resequencing regions, and these genetic variants focus on biological mechanisms of host defense and cell senescence. |
Author | Mogulkoc, Nesrin Powers, Julie Glaspole, Ian Ma, Shwu-Fan Vašáková, Martina Moore, Camille Henry, Michael T. Machahua, Carlos Inoue, Yoshikazu Blumhagen, Rachel Z. Gudmundsson, Gunnar Furusawa, Haruhiko Kim, Dong Soon Kreider, Maryl E. Walker, Tarik Cho, Michael H. Montesi, Sydney B. Brown, Kevin K. Fernandez, Isis Enlil Fiddler, Christine Steele, Mark P. Kim, Hocheol Akagawa, Shinobu Lederer, David J. Song, Jin Woo Wilcox, Pearce G. Cogan, Joy D. Baltic, Svetlana Prele, Cecilia Russell, Pamela Porteous, Mary K. Pacheco, Karin A. Selman, Moises Podolanczuk, Anna J. Bishop, Makenna Strek, Mary E. Guthridge, Joel M. Mathai, Susan K. Silverman, Edwin K. Zhang, Yingze Okamoto, Tsukasa Worboys, Ana Montes Tomassetti, Sara Sundy, John S. Molyneaux, Philip L. Isaksson, Helgi J. Laurent, Geoffrey Wolters, Paul J. Saunders, Peter Yang, Ivana V. Maier, Lisa A. Eickelberg, Oliver Markin, Cheryl R. Doran, Peter James, Judith A. O’Riordan, Thomas Li, Feng Sterclova, Martina Pardo, Annie Poletti, Venerino Braybrooke, Rebecca Sembrat, John Gibson, Kevin F. Colla |
Author_xml | – sequence: 1 givenname: Camille surname: Moore fullname: Moore, Camille organization: National Jewish Health, Denver, Colorado, School of Public Health – sequence: 2 givenname: Rachel Z. surname: Blumhagen fullname: Blumhagen, Rachel Z. organization: National Jewish Health, Denver, Colorado, School of Public Health – sequence: 3 givenname: Ivana V. surname: Yang fullname: Yang, Ivana V. organization: Department of Medicine, and – sequence: 4 givenname: Avram surname: Walts fullname: Walts, Avram organization: Department of Medicine, and – sequence: 5 givenname: Julie surname: Powers fullname: Powers, Julie organization: Department of Medicine, and – sequence: 6 givenname: Tarik surname: Walker fullname: Walker, Tarik organization: Department of Medicine, and – sequence: 7 givenname: Makenna surname: Bishop fullname: Bishop, Makenna organization: Department of Medicine, and – sequence: 8 givenname: Pamela surname: Russell fullname: Russell, Pamela organization: National Jewish Health, Denver, Colorado – sequence: 9 givenname: Brian surname: Vestal fullname: Vestal, Brian organization: National Jewish Health, Denver, Colorado – sequence: 10 givenname: Jonathan surname: Cardwell fullname: Cardwell, Jonathan organization: Department of Medicine, and – sequence: 11 givenname: Cheryl R. surname: Markin fullname: Markin, Cheryl R. organization: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee – sequence: 12 givenname: Susan K. surname: Mathai fullname: Mathai, Susan K. organization: Department of Medicine, and – sequence: 13 givenname: Marvin I. surname: Schwarz fullname: Schwarz, Marvin I. organization: Department of Medicine, and – sequence: 14 givenname: Mark P. surname: Steele fullname: Steele, Mark P. organization: Department of Medicine, and – sequence: 15 givenname: Joyce surname: Lee fullname: Lee, Joyce organization: Department of Medicine, and – sequence: 16 givenname: Kevin K. surname: Brown fullname: Brown, Kevin K. organization: National Jewish Health, Denver, Colorado – sequence: 17 givenname: James E. surname: Loyd fullname: Loyd, James E. organization: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee – sequence: 18 givenname: James D. surname: Crapo fullname: Crapo, James D. organization: National Jewish Health, Denver, Colorado, Department of Medicine, and – sequence: 19 givenname: Edwin K. surname: Silverman fullname: Silverman, Edwin K. organization: Brigham and Women’s Hospital, Harvard School of Medicine, Boston, Massachusetts – sequence: 20 givenname: Michael H. surname: Cho fullname: Cho, Michael H. organization: Brigham and Women’s Hospital, Harvard School of Medicine, Boston, Massachusetts – sequence: 21 givenname: Judith A. surname: James fullname: James, Judith A. organization: Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma – sequence: 22 givenname: Joel M. surname: Guthridge fullname: Guthridge, Joel M. organization: Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma – sequence: 23 givenname: Joy D. surname: Cogan fullname: Cogan, Joy D. organization: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee – sequence: 24 givenname: Jonathan A. surname: Kropski fullname: Kropski, Jonathan A. organization: Department of Medicine, Vanderbilt University School of Medicine, Nashville, Tennessee – sequence: 25 givenname: Jeffrey J. surname: Swigris fullname: Swigris, Jeffrey J. organization: National Jewish Health, Denver, Colorado – sequence: 26 givenname: Carol surname: Bair fullname: Bair, Carol organization: National Jewish Health, Denver, Colorado – sequence: 27 givenname: Dong Soon surname: Kim fullname: Kim, Dong Soon organization: Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 28 givenname: Wonjun surname: Ji fullname: Ji, Wonjun organization: Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 29 givenname: Hocheol surname: Kim fullname: Kim, Hocheol organization: Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 30 givenname: Jin Woo surname: Song fullname: Song, Jin Woo organization: Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea – sequence: 31 givenname: Lisa A. surname: Maier fullname: Maier, Lisa A. organization: National Jewish Health, Denver, Colorado, School of Public Health, Department of Medicine, and – sequence: 32 givenname: Karin A. surname: Pacheco fullname: Pacheco, Karin A. organization: National Jewish Health, Denver, Colorado, School of Public Health – sequence: 33 givenname: Nikhil surname: Hirani fullname: Hirani, Nikhil organization: MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom, Respiratory Medicine Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom – sequence: 34 givenname: Azin S. surname: Poon fullname: Poon, Azin S. organization: Respiratory Medicine Unit, Royal Infirmary of Edinburgh, Edinburgh, United Kingdom – sequence: 35 givenname: Feng surname: Li fullname: Li, Feng organization: MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom – sequence: 36 givenname: R. Gisli surname: Jenkins fullname: Jenkins, R. Gisli organization: Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom – sequence: 37 givenname: Rebecca surname: Braybrooke fullname: Braybrooke, Rebecca organization: Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom – sequence: 38 givenname: Gauri surname: Saini fullname: Saini, Gauri organization: Biomedical Research Centre, University of Nottingham, Nottingham, United Kingdom – sequence: 39 givenname: Toby M. surname: Maher fullname: Maher, Toby M. organization: Royal Brompton Hospital and Imperial College, London, United Kingdom – sequence: 40 givenname: Philip L. surname: Molyneaux fullname: Molyneaux, Philip L. organization: Royal Brompton Hospital and Imperial College, London, United Kingdom – sequence: 41 givenname: Peter surname: Saunders fullname: Saunders, Peter organization: Royal Brompton Hospital and Imperial College, London, United Kingdom – sequence: 42 givenname: Yingze surname: Zhang fullname: Zhang, Yingze organization: Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania – sequence: 43 givenname: Kevin F. surname: Gibson fullname: Gibson, Kevin F. organization: Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania – sequence: 44 givenname: Daniel J. surname: Kass fullname: Kass, Daniel J. organization: Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania – sequence: 45 givenname: Mauricio surname: Rojas fullname: Rojas, Mauricio organization: Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania – sequence: 46 givenname: John surname: Sembrat fullname: Sembrat, John organization: Simmons Center for Interstitial Lung Disease, University of Pittsburgh, Pittsburgh, Pennsylvania – sequence: 47 givenname: Paul J. surname: Wolters fullname: Wolters, Paul J. organization: Department of Medicine, University of California, San Francisco, San Francisco, California – sequence: 48 givenname: Harold R. surname: Collard fullname: Collard, Harold R. organization: Department of Medicine, University of California, San Francisco, San Francisco, California – sequence: 49 givenname: John S. surname: Sundy fullname: Sundy, John S. organization: Gilead Sciences, Foster City, California – sequence: 50 givenname: Thomas surname: O’Riordan fullname: O’Riordan, Thomas organization: Gilead Sciences, Foster City, California – sequence: 51 givenname: Mary E. surname: Strek fullname: Strek, Mary E. organization: Department of Medicine, University of Chicago, Chicago, Illinois – sequence: 52 givenname: Imre surname: Noth fullname: Noth, Imre organization: Department of Medicine, University of Virginia, Charlottesville, Virginia – sequence: 53 givenname: Shwu-Fan surname: Ma fullname: Ma, Shwu-Fan organization: Department of Medicine, University of Virginia, Charlottesville, Virginia – sequence: 54 givenname: Mary K. surname: Porteous fullname: Porteous, Mary K. organization: Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania – sequence: 55 givenname: Maryl E. surname: Kreider fullname: Kreider, Maryl E. organization: Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania – sequence: 56 givenname: Namrata B. surname: Patel fullname: Patel, Namrata B. organization: Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania – sequence: 57 givenname: Yoshikazu orcidid: 0000-0003-3994-874X surname: Inoue fullname: Inoue, Yoshikazu organization: National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan – sequence: 58 givenname: Masaki surname: Hirose fullname: Hirose, Masaki organization: National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan – sequence: 59 givenname: Toru surname: Arai fullname: Arai, Toru organization: National Hospital Organization Kinki-Chuo Chest Medical Center, Osaka, Japan – sequence: 60 givenname: Shinobu surname: Akagawa fullname: Akagawa, Shinobu organization: National Hospital Organization Tokyo National Hospital, Tokyo, Japan – sequence: 61 givenname: Oliver orcidid: 0000-0001-7170-0360 surname: Eickelberg fullname: Eickelberg, Oliver organization: Department of Medicine, and, Helmholtz Zentrum München, Neuherberg, Germany – sequence: 62 givenname: Isis Enlil surname: Fernandez fullname: Fernandez, Isis Enlil organization: Helmholtz Zentrum München, Neuherberg, Germany – sequence: 63 givenname: Jürgen surname: Behr fullname: Behr, Jürgen organization: University Hospital Munich, Munich, Germany – sequence: 64 givenname: Nesrin surname: Mogulkoc fullname: Mogulkoc, Nesrin organization: Department of Pulmonology, Ege University Hospital, Bornova, Izmir, Turkey – sequence: 65 givenname: Tamera J. surname: Corte fullname: Corte, Tamera J. organization: Royal Prince Alfred Hospital and University of Sydney, Sydney, Australia – sequence: 66 givenname: Ian surname: Glaspole fullname: Glaspole, Ian organization: Alfred Hospital and Monash University, Melbourne, Australia – sequence: 67 givenname: Sara surname: Tomassetti fullname: Tomassetti, Sara organization: Pulmonary Medicine, GB Morgagni Hospital, Forlì, Italy – sequence: 68 givenname: Claudia surname: Ravaglia fullname: Ravaglia, Claudia organization: Department of Diseases of the Thorax, Ospedale GB Morgagni, Forlì, Italy – sequence: 69 givenname: Venerino surname: Poletti fullname: Poletti, Venerino organization: Department of Diseases of the Thorax, Ospedale GB Morgagni, Forlì, Italy – sequence: 70 givenname: Bruno surname: Crestani fullname: Crestani, Bruno organization: Université Paris Diderot and Hôpital Bichat, Paris, France – sequence: 71 givenname: Raphael surname: Borie fullname: Borie, Raphael organization: Université Paris Diderot and Hôpital Bichat, Paris, France – sequence: 72 givenname: Caroline surname: Kannengiesser fullname: Kannengiesser, Caroline organization: Université Paris Diderot and Hôpital Bichat, Paris, France – sequence: 73 givenname: Helen surname: Parfrey fullname: Parfrey, Helen organization: Royal Papworth Hospital and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom – sequence: 74 givenname: Christine surname: Fiddler fullname: Fiddler, Christine organization: Royal Papworth Hospital and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom – sequence: 75 givenname: Doris surname: Rassl fullname: Rassl, Doris organization: Royal Papworth Hospital and Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom – sequence: 76 givenname: Maria surname: Molina-Molina fullname: Molina-Molina, Maria organization: Respiratory Department, University Hospital of Bellvitge, University of Barcelona, Barcelona, Spain – sequence: 77 givenname: Carlos surname: Machahua fullname: Machahua, Carlos organization: Respiratory Department, University Hospital of Bellvitge, University of Barcelona, Barcelona, Spain – sequence: 78 givenname: Ana Montes surname: Worboys fullname: Worboys, Ana Montes organization: Respiratory Department, University Hospital of Bellvitge, University of Barcelona, Barcelona, Spain – sequence: 79 givenname: Gunnar surname: Gudmundsson fullname: Gudmundsson, Gunnar organization: National University Hospital of Iceland, University of Iceland, Reykjavik, Iceland – sequence: 80 givenname: Helgi J. surname: Isaksson fullname: Isaksson, Helgi J. organization: National University Hospital of Iceland, University of Iceland, Reykjavik, Iceland – sequence: 81 givenname: David J. orcidid: 0000-0001-5258-0228 surname: Lederer fullname: Lederer, David J. organization: Department of Medicine, Columbia University Irving Medical Center, New York, New York – sequence: 82 givenname: Anna J. surname: Podolanczuk fullname: Podolanczuk, Anna J. organization: Department of Medicine, Columbia University Irving Medical Center, New York, New York – sequence: 83 givenname: Sydney B. surname: Montesi fullname: Montesi, Sydney B. organization: Division of Pulmonary and Critical Care Medicine, Massachusetts General Hospital, Boston, Massachusetts – sequence: 84 givenname: Elisabeth surname: Bendstrup fullname: Bendstrup, Elisabeth organization: Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark – sequence: 85 givenname: Vivi surname: Danchel fullname: Danchel, Vivi organization: Department of Respiratory Diseases and Allergy, Aarhus University Hospital, Aarhus, Denmark – sequence: 86 givenname: Moises surname: Selman fullname: Selman, Moises organization: Instituto Nacional de Enfermedades Respiratorias “Ismael Cosio Villegas,” México City, México – sequence: 87 givenname: Annie surname: Pardo fullname: Pardo, Annie organization: Universidad Nacional Autónoma de México, México City, México – sequence: 88 givenname: Michael T. surname: Henry fullname: Henry, Michael T. organization: Cork University Hospital and University College Cork, Cork, Ireland – sequence: 89 givenname: Michael P. surname: Keane fullname: Keane, Michael P. organization: St. Vincent’s University Hospital, Dublin, Ireland, School of Medicine, University College Dublin, Dublin, Ireland – sequence: 90 givenname: Peter surname: Doran fullname: Doran, Peter organization: St. Vincent’s University Hospital, Dublin, Ireland, School of Medicine, University College Dublin, Dublin, Ireland – sequence: 91 givenname: Martina surname: Vašáková fullname: Vašáková, Martina organization: Department of Respiratory Medicine, First Faculty of Medicine Charles University and Thomayer Hospital, Prague, Czech Republic – sequence: 92 givenname: Martina surname: Sterclova fullname: Sterclova, Martina organization: Department of Respiratory Medicine, First Faculty of Medicine Charles University and Thomayer Hospital, Prague, Czech Republic – sequence: 93 givenname: Christopher J. surname: Ryerson fullname: Ryerson, Christopher J. organization: University of British Columbia, Vancouver, Canada – sequence: 94 givenname: Pearce G. surname: Wilcox fullname: Wilcox, Pearce G. organization: University of British Columbia, Vancouver, Canada – sequence: 95 givenname: Tsukasa surname: Okamoto fullname: Okamoto, Tsukasa organization: Department of Medicine, and, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 96 givenname: Haruhiko surname: Furusawa fullname: Furusawa, Haruhiko organization: Department of Medicine, and, Tokyo Medical and Dental University, Tokyo, Japan – sequence: 97 givenname: Yasunari surname: Miyazaki fullname: Miyazaki, Yasunari organization: Tokyo Medical and Dental University, Tokyo, Japan – sequence: 98 givenname: Geoffrey surname: Laurent fullname: Laurent, Geoffrey organization: Institute for Respiratory Health and, Centre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, The University of Western Australia, Perth, Australia – sequence: 99 givenname: Svetlana surname: Baltic fullname: Baltic, Svetlana organization: Institute for Respiratory Health and – sequence: 100 givenname: Cecilia surname: Prele fullname: Prele, Cecilia organization: Institute for Respiratory Health and, Centre for Cell Therapy and Regenerative Medicine, School of Biomedical Sciences, The University of Western Australia, Perth, Australia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31034279$$D View this record in MEDLINE/PubMed |
BookMark | eNp9kk1rFTEYhYNU7If-ARcScONmaj7mJjMbQUb7AYVKW8VdyGTe9KbOJLdJRugv6N9uhtuKduEqgTzn8L4nZx_t-OABobeUHFIq6o_RmOmQEdpQUtGmpefdC7RHV3xV1a0kO-VOJK_quv25i_ZTuiGEssK-QrucEl4z2e6h-wtIcDuDN85f48s8D3e4C966OCV8tdYZn4SU8Rew4BNg7QfcwTjiS_CQTJEBPi5X_ENHp31OizhH188ZcA44rwFfuPQLB4tPBxc2Oq-dwd_mcQpexzt85PoYkkuv0UurxwRvHs8D9P3o61V3Up2dH592n88qU3OSKymo0Cth2gZ6DkAbMFYQA9b2WmhLgQ-WS9a3TDJOBtMLQ5lhNeWWU9YzfoA-bX03cz_BUDbIUY9qE91UxlFBO_Xvi3drdR1-KyH4Sra0GHx4NIih5JaymlwJYhy1hzAnxRiVdcMElQV9_wy9CXP0Zb1CtURKLtuFevf3RH9GefqjAjRbwJSkUgSrjMs6uyVo7UZFiVrqoJY6qG0d1LYORcqeSZ_c_yN6AEIqu-o |
CitedBy_id | crossref_primary_10_1016_j_exger_2020_110836 crossref_primary_10_1186_s12931_021_01694_z crossref_primary_10_1002_ajmg_a_62986 crossref_primary_10_2147_JIR_S280958 crossref_primary_10_1096_fj_201902636RR crossref_primary_10_1164_rccm_202109_2166OC crossref_primary_10_1164_rccm_202002_0360UP crossref_primary_10_1183_13993003_02533_2020 crossref_primary_10_1164_rccm_202110_2308OC crossref_primary_10_1016_j_semcdb_2019_12_008 crossref_primary_10_3390_diagnostics12122928 crossref_primary_10_1159_000513290 crossref_primary_10_1016_j_arbres_2019_08_002 crossref_primary_10_1172_JCI183836 crossref_primary_10_1164_rccm_202004_1274OC crossref_primary_10_1016_j_alit_2024_04_002 crossref_primary_10_1164_rccm_201911_2286ED crossref_primary_10_3390_ijms22126214 crossref_primary_10_1111_resp_13803 crossref_primary_10_1007_s00408_023_00652_4 crossref_primary_10_1016_j_arth_2020_05_070 crossref_primary_10_1089_dna_2019_4892 crossref_primary_10_1186_s13023_021_01750_3 crossref_primary_10_3390_jcm11061747 crossref_primary_10_1136_thoraxjnl_2021_217693 crossref_primary_10_1007_s11033_020_05861_1 crossref_primary_10_1016_j_trsl_2021_09_001 crossref_primary_10_1183_13993003_03979_2020 crossref_primary_10_1111_ahg_12509 crossref_primary_10_18632_aging_204825 crossref_primary_10_3389_fphar_2021_797292 crossref_primary_10_1016_j_chest_2020_03_037 crossref_primary_10_1164_rccm_202206_1075OC crossref_primary_10_1080_17476348_2025_2464035 crossref_primary_10_1016_j_xgen_2021_100005 crossref_primary_10_3389_fimmu_2021_796932 crossref_primary_10_3390_jcm10235562 crossref_primary_10_1093_qjmed_hcad269 crossref_primary_10_1016_j_pharmthera_2023_108528 crossref_primary_10_1152_ajpcell_00239_2023 crossref_primary_10_1164_rccm_202207_1331OC crossref_primary_10_1016_j_cellsig_2019_109482 crossref_primary_10_1164_rccm_202110_2439OC crossref_primary_10_3390_ijms241310748 crossref_primary_10_1038_s41419_022_04886_7 crossref_primary_10_1183_16000617_0053_2019 crossref_primary_10_1159_000508558 crossref_primary_10_1016_j_cmet_2023_08_008 crossref_primary_10_1172_jci_insight_144294 crossref_primary_10_1016_j_chest_2024_10_042 crossref_primary_10_1080_08958378_2020_1825569 crossref_primary_10_1186_s12890_021_01749_3 crossref_primary_10_1084_jem_20220170 crossref_primary_10_3390_cells10102763 crossref_primary_10_1016_S2213_2600_22_00270_3 crossref_primary_10_3389_fimmu_2023_1308594 crossref_primary_10_3390_cells11203319 crossref_primary_10_1186_s12931_023_02554_8 crossref_primary_10_1164_rccm_202309_1573PP crossref_primary_10_1111_his_14334 crossref_primary_10_3389_fmed_2021_739810 crossref_primary_10_1016_j_apsb_2021_07_023 crossref_primary_10_1186_s10020_024_00990_w crossref_primary_10_1164_rccm_201905_0925ED crossref_primary_10_1007_s00292_019_00747_x crossref_primary_10_3389_fmed_2020_611728 crossref_primary_10_1186_s12890_022_01927_x crossref_primary_10_1164_rccm_201905_1017OC crossref_primary_10_1097_MCP_0000000000000989 crossref_primary_10_3390_ncrna8060083 crossref_primary_10_1164_rccm_202307_1154WS crossref_primary_10_3389_fcell_2020_580026 crossref_primary_10_1164_rccm_202401_0238SO crossref_primary_10_1097_MCP_0000000000000706 crossref_primary_10_1038_s41572_020_0191_z crossref_primary_10_3390_life13020486 crossref_primary_10_1164_rccm_202301_0177ED crossref_primary_10_1165_rcmb_2020_0546OC crossref_primary_10_1007_s00428_020_02964_9 crossref_primary_10_1016_j_arbr_2019_08_014 crossref_primary_10_1165_rcmb_2020_0373PS crossref_primary_10_3390_ijms242216481 crossref_primary_10_1016_j_pharmthera_2020_107798 crossref_primary_10_1016_j_gene_2023_147993 |
Cites_doi | 10.1111/resp.12466 10.1164/rccm.201509-1863OC 10.1038/ng.2609 10.1164/rccm.201509-1872LE 10.1016/j.ajhg.2012.06.007 10.1056/NEJM200102223440805 10.1016/S2213-2600(13)70045-6 10.1056/NEJMoa066157 10.1038/nrdp.2017.74 10.1164/rccm.201807-1255ST 10.1186/s12863-016-0377-2 10.1038/ng.3752 10.1056/NEJMoa1013660 10.1016/S2213-2600(17)30387-9 10.1038/nature24277 10.1073/pnas.0901259106 10.1165/rcmb.2017-0046OC 10.4161/fly.19695 10.1038/ng.3278 10.1073/pnas.0701009104 10.1371/journal.pone.0104919 10.1016/j.ajhg.2008.11.010 10.1093/nar/gkx1098 10.1126/science.1200120 10.1126/science.1223012 10.1152/physrev.00004.2016 10.1016/S2213-2600(18)30135-8 |
ContentType | Journal Article |
Copyright | Copyright American Thoracic Society Jul 15, 2019 Copyright © 2019 by the American Thoracic Society 2019 |
Copyright_xml | – notice: Copyright American Thoracic Society Jul 15, 2019 – notice: Copyright © 2019 by the American Thoracic Society 2019 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7RV 7X7 7XB 88E 8AO 8C1 8FI 8FJ 8FK ABUWG AFKRA AN0 BENPR CCPQU FYUFA GHDGH K9. KB0 M0S M1P NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1164/rccm.201810-1891OC |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) ProQuest Nursing & Allied Health Database ProQuest Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest British Nursing Database ProQuest Central ProQuest One Community College Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) ProQuest Health & Medical Collection Proquest Medical Database Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest Public Health ProQuest One Academic Eastern Edition British Nursing Index with Full Text ProQuest Nursing & Allied Health Source ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | MEDLINE ProQuest One Academic Middle East (New) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1535-4970 |
EndPage | 208 |
ExternalDocumentID | PMC6635791 31034279 10_1164_rccm_201810_1891OC |
Genre | Research Support, Non-U.S. Gov't Journal Article Research Support, N.I.H., Extramural |
GeographicLocations | New York United Kingdom--UK United States--US Japan Oklahoma California Iceland Pennsylvania San Francisco California Turkey Ireland Colorado Massachusetts Italy Virginia Aarhus Denmark Germany |
GeographicLocations_xml | – name: New York – name: Pennsylvania – name: Iceland – name: Colorado – name: Italy – name: Japan – name: Oklahoma – name: United States--US – name: Turkey – name: Germany – name: California – name: Ireland – name: United Kingdom--UK – name: Aarhus Denmark – name: San Francisco California – name: Virginia – name: Massachusetts |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: R33 HL120770 – fundername: NCRR NIH HHS grantid: UL1 RR024975 – fundername: NHLBI NIH HHS grantid: U01 HL089897 – fundername: NIAMS NIH HHS grantid: P30 AR073750 – fundername: NHLBI NIH HHS grantid: UH3 HL123442 – fundername: NIAMS NIH HHS grantid: P30 AR053483 – fundername: NHLBI NIH HHS grantid: P01 HL092870 – fundername: NHLBI NIH HHS grantid: K08 HL130595 – fundername: NHLBI NIH HHS grantid: T32 HL007085 – fundername: Medical Research Council grantid: MR/N005953/1 |
GroupedDBID | --- -~X .55 0R~ 23M 2WC 34G 39C 53G 5GY 5RE 7RV 7X7 88E 8AO 8C1 8FI 8FJ 8FW 8R4 8R5 AAQQT AAWTL AAYXX ABJNI ABOCM ABPMR ABUWG ACGFO ACGFS ADBBV AENEX AFCHL AFKRA AHMBA ALIPV ALMA_UNASSIGNED_HOLDINGS AN0 BAWUL BENPR BKEYQ BNQBC BPHCQ BVXVI C45 CCPQU CITATION CS3 DIK E3Z EBS EJD EMOBN EX3 F5P FRP FYUFA GX1 H13 HMCUK HZ~ IH2 J5H KQ8 L7B M1P M5~ NAPCQ O9- OBH OFXIZ OGEVE OK1 OVD OVIDX P2P PCD PHGZM PHGZT PQQKQ PROAC PSQYO Q2X RWL SJN TAE TEORI THO TR2 UKHRP W8F WH7 WOQ WOW X7M ~02 CGR CUY CVF ECM EIF NPM PJZUB PPXIY 3V. 7XB 8FK K9. PKEHL PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c430t-7616a56c98eb3ee18ecf60ceffba6af1e3df372b927230dcb6c12c2413f312b23 |
IEDL.DBID | 7X7 |
ISSN | 1073-449X 1535-4970 |
IngestDate | Thu Aug 21 18:11:31 EDT 2025 Fri Jul 11 07:32:31 EDT 2025 Fri Jul 25 08:49:27 EDT 2025 Mon Jul 21 06:02:45 EDT 2025 Thu Apr 24 22:55:53 EDT 2025 Tue Jul 01 02:01:10 EDT 2025 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Keywords | genetic variants rare variants idiopathic pulmonary fibrosis targeted resequencing disease risk alleles |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c430t-7616a56c98eb3ee18ecf60ceffba6af1e3df372b927230dcb6c12c2413f312b23 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Deceased. These authors contributed equally as senior authors. These authors contributed equally as first authors. T.M.M., H.R.C., and O.E. are Associate Editors of AJRCCM. Their participation complies with American Thoracic Society requirements for recusal from review and decisions for authored works. |
ORCID | 0000-0003-3994-874X 0000-0001-7170-0360 0000-0001-5258-0228 |
OpenAccessLink | https://pure.au.dk/portal/en/publications/258420f8-69ac-4cf4-a775-b16eec718300 |
PMID | 31034279 |
PQID | 2290773797 |
PQPubID | 40575 |
PageCount | 10 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_6635791 proquest_miscellaneous_2217482617 proquest_journals_2290773797 pubmed_primary_31034279 crossref_citationtrail_10_1164_rccm_201810_1891OC crossref_primary_10_1164_rccm_201810_1891OC |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2019-07-15 |
PublicationDateYYYYMMDD | 2019-07-15 |
PublicationDate_xml | – month: 07 year: 2019 text: 2019-07-15 day: 15 |
PublicationDecade | 2010 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States – name: New York |
PublicationTitle | American journal of respiratory and critical care medicine |
PublicationTitleAlternate | Am J Respir Crit Care Med |
PublicationYear | 2019 |
Publisher | American Thoracic Society |
Publisher_xml | – name: American Thoracic Society |
References | bib14 bib12 bib13 bib10 bib11 bib29 bib28 bib25 bib26 bib23 bib24 bib21 bib22 bib20 bib9 bib7 bib8 bib5 bib18 bib6 bib19 bib3 bib16 bib4 bib17 bib1 bib2 31113211 - Am J Respir Crit Care Med. 2019 Jul 15;200(2):125-127. doi: 10.1164/rccm.201905-0925ED. |
References_xml | – ident: bib11 doi: 10.1111/resp.12466 – ident: bib19 doi: 10.1164/rccm.201509-1863OC – ident: bib6 doi: 10.1038/ng.2609 – ident: bib28 doi: 10.1164/rccm.201509-1872LE – ident: bib14 doi: 10.1016/j.ajhg.2012.06.007 – ident: bib2 doi: 10.1056/NEJM200102223440805 – ident: bib7 doi: 10.1016/S2213-2600(13)70045-6 – ident: bib3 doi: 10.1056/NEJMoa066157 – ident: bib1 doi: 10.1038/nrdp.2017.74 – ident: bib13 doi: 10.1164/rccm.201807-1255ST – ident: bib8 doi: 10.1186/s12863-016-0377-2 – ident: bib22 doi: 10.1038/ng.3752 – ident: bib24 doi: 10.1056/NEJMoa1013660 – ident: bib9 doi: 10.1016/S2213-2600(17)30387-9 – ident: bib18 doi: 10.1038/nature24277 – ident: bib20 doi: 10.1073/pnas.0901259106 – ident: bib25 doi: 10.1165/rcmb.2017-0046OC – ident: bib17 doi: 10.4161/fly.19695 – ident: bib5 doi: 10.1038/ng.3278 – ident: bib23 doi: 10.1073/pnas.0701009104 – ident: bib10 doi: 10.1371/journal.pone.0104919 – ident: bib4 doi: 10.1016/j.ajhg.2008.11.010 – ident: bib16 doi: 10.1093/nar/gkx1098 – ident: bib21 doi: 10.1126/science.1200120 – ident: bib29 doi: 10.1126/science.1223012 – ident: bib26 doi: 10.1152/physrev.00004.2016 – ident: bib12 doi: 10.1016/S2213-2600(18)30135-8 – reference: 31113211 - Am J Respir Crit Care Med. 2019 Jul 15;200(2):125-127. doi: 10.1164/rccm.201905-0925ED. |
SSID | ssj0012810 |
Score | 2.5677872 |
Snippet | Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized to the... Rationale: Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized... Rationale: Several common and rare genetic variants have been associated with idiopathic pulmonary fibrosis, a progressive fibrotic condition that is localized... |
SourceID | pubmedcentral proquest pubmed crossref |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source |
StartPage | 199 |
SubjectTerms | ATP-Binding Cassette Transporters - genetics Case-Control Studies Cellular Senescence - genetics DNA Helicases - genetics Exoribonucleases - genetics Family medical history Female Gene loci Genealogy Genetic Predisposition to Disease Genetic Variation Genome-Wide Association Study Genomes Genomics GTPase-Activating Proteins - genetics High-Throughput Nucleotide Sequencing Hospitals Host-Pathogen Interactions - genetics Humans Idiopathic Pulmonary Fibrosis - genetics Logistic Models Lung diseases Male Medicine Mucin-5B - genetics Mutation Original Promoter Regions, Genetic - genetics Pulmonary fibrosis Pulmonary Surfactant-Associated Protein A - genetics Pulmonary Surfactant-Associated Protein C - genetics RNA - genetics Senescence Sequence Analysis, DNA Telomerase - genetics Telomere-Binding Proteins - genetics University colleges |
Title | Resequencing Study Confirms That Host Defense and Cell Senescence Gene Variants Contribute to the Risk of Idiopathic Pulmonary Fibrosis |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31034279 https://www.proquest.com/docview/2290773797 https://www.proquest.com/docview/2217482617 https://pubmed.ncbi.nlm.nih.gov/PMC6635791 |
Volume | 200 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1Lb9QwELaglRCXivIMtJWRuCGrceK14xOCpasFiVKVFu0tcvxQI7ZJ2WQP_QX8bWaSbGBB6iUX20risT3zeWa-IeRN7GMdAHkwncSGCS8FK5TzDHSB0FnINC86ts9TOb8UnxeTxXDh1gxhlZszsTuoXW3xjvwYecmVSpVW725-Mqwahd7VoYTGfbKL1GUY0qUWI-BCJ1HPRqBSJoRebJJmpDheWYt56KDf0LWp-dfptmL6z9r8N2jyLy00e0T2BvORvu_lvU_u-eoxefBlcJA_Ib8wkq4LjgaVRDFI8JZiUl-5um7oxZVp6bxuWvrRB4CvnprK0alfLuk3PPIs7nKKRNT0O0BojJDBwX1NLE_bmoK1SM_L5getA_3kyrqrZ2zp2XoJ02NWt3QG6LtuyuYpuZydXEznbKi1wKxI45YpyaWZSKszQNfe88zbIGPrQyiMNIH71IVUJYVOFIAWZwtpeWLRKRdSnhRJ-ozsVHXlX2AWuLMiiDTRLhUAME2hYmOcdRrWhVKTiPDNROd2ICLHehjLvAMkUuQonLwXTt4LJyJvxzE3PQ3Hnb0PNvLLhy3Z5H8WUERej82wmdBDYipfr7EPALQMSeoj8rwX9_g6LMgmEqUjorYWwtgBibq3W6ryqiPsRqtOaf7y7s96RR7CX2BKGeOTA7LTrtb-ECyetjjqljU8syk_IrsfTk7Pzn8DBlAD6g |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9NAEF5VqQRcEG9MCywSnJBVe73xeg8IQdoooW2oSopyc9frXdUitUvsCOUX8G_4jcz4EQhIvfXsXfkxszPzeWa-IeS1ZzxpAXm4knnK5SbkbiJS44Iv4DKykfSTmu1zEo7O-KdZf7ZFfnW9MFhW2dnE2lCnhcZ_5HvISy5EIKR4f_XdxalRmF3tRmg0anFoVj8AspXvxvsg3zeMDQ-mg5HbThVwNQ-8ygXcHqp-qGUEONIYPzLahp421iYqVNY3QWoDwRLJBITnqU5C7TON6Scb-CxBogMw-ds8ACjTI9sfDyYnp-u8BYta_gMRuJzLWdemE_K9hdbY-Q4eFZOp0v882HSF_8W3_5Zp_uX3hvfI3TZgpR8aDbtPtkz-gNw6blPyD8lPrN2ry7HBCVIsS1xRbCPMFpclnV6oio6KsqL7xgJgNlTlKR2Y-Zx-QSOr0a5QpL6mXwG0Y00Obm6mcBlaFRTiU3qald9oYek4zYp6grKmJ8s5CEQtVnQIeL8os_IRObsROTwmvbzIzVPsO081tzxgMg04QFqVCE-pVKcSNFGIvkP87kPHuqU-xwkc87iGQCGPUThxI5y4EY5D3q73XDXEH9eu3u3kF7dGoIz_qKxDXq0vw_HFnIzKTbHENQAJI6TFd8iTRtzr2-EIOM6EdIjYUIT1AqQG37ySZxc1RTjGkUL6z65_rJfk9mh6fBQfjSeHO-QOvBE2tLl-f5f0qsXSPId4q0petEpOyflNn6vfhZhA2g |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Lb9QwELaqIlVcEG_SFjASnJC1eThxfEAI7bLapVAqaNHeguPYasQ2KZus0P4C_hO_jpm8YEHqrefYymPGM_NlZr4h5LlrXGkBeTDpu4pxE3GWisww8AVcxjaWXtqwfR5HszP-bhEudsivvhcGyyp7m9gY6qzU-I98hLzkQgRCipHtyiJOJtPXl98ZTpDCTGs_TqNVkSOz-QHwrXo1n4CsX_j-9O3peMa6CQNM88CtGWD4SIWRljFgSmO82GgbudpYm6pIWc8EmQ2En0pfQKie6TTSnq8xFWUDz0-R9ADM_w0RhB6eMbEYwB4mqFomBBEwzuWib9iJ-GilNfbAg2_FtKr0Po63neJ_ke6_BZt_ecDpbXKrC13pm1bX7pAdU9wlex-65Pw98hOr-JrCbHCHFAsUNxQbCvPVRUVPz1VNZ2VV04mxAJ0NVUVGx2a5pJ_R3Gq0MBRJsOkXgO9YnYOb23lchtYlhUiVfsqrb7S0dJ7lZTNLWdOT9RLEoVYbOgXkX1Z5dZ-cXYsUHpDdoizMI-xAzzS3PPBlFnAAtyoVrlKZziTopBChQ7z-Qye6I0HHWRzLpAFDEU9QOEkrnKQVjkNeDnsuWwqQK1cf9vJLOnNQJX-U1yHPhstwkDE7owpTrnENgMMYCfId8rAV93A7HAbHfSEdIrYUYViAJOHbV4r8vCELx4hSSG__6sd6SvbgNCXv58dHB-QmvBB2tjEvPCS79WptHkPgVadPGg2n5Ot1H6nfv9tDqg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Resequencing+Study+Confirms+That+Host+Defense+and+Cell+Senescence+Gene+Variants+Contribute+to+the+Risk+of+Idiopathic+Pulmonary+Fibrosis&rft.jtitle=American+journal+of+respiratory+and+critical+care+medicine&rft.au=Blumhagen%2C+Rachel+Z&rft.au=Yang%2C+Ivana+V&rft.au=Walker%2C+Tarik&rft.au=Bishop%2C+Makenna&rft.date=2019-07-15&rft.pub=American+Thoracic+Society&rft.issn=1073-449X&rft.eissn=1535-4970&rft.volume=200&rft.issue=2&rft.spage=199&rft_id=info:doi/10.1164%2Frccm.201810-1891OC&rft.externalDBID=HAS_PDF_LINK |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1073-449X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1073-449X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1073-449X&client=summon |